SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-015694
Filing Date
2024-04-23
Accepted
2024-04-23 16:05:19
Documents
6
Period of Report
2024-04-23

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 738607
2 formdef14a_001.jpg GRAPHIC 15784
3 formdef14a_003.jpg GRAPHIC 66400
4 formdef14a_004.jpg GRAPHIC 53922
5 proxy_001.jpg GRAPHIC 253635
6 proxy_002.jpg GRAPHIC 184145
  Complete submission text file 0001493152-24-015694.txt   1530674
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36357 | Film No.: 24864821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)